arrow
F

Fuliang Chu

ut md anderson cancer center
H指数:22
被引数:3,318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

pembrolizumab联合利妥昔单抗治疗复发或难治性滤泡性淋巴瘤的安全性和活性

2022-02-1433
OAAI
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity
LEUKEMIA
IF13.4
2019-04-2540
OAAI